Content area
Novartis Pharmaceuticals Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Novartis Pharmaceuticals Corp (Novartis), a subsidiary of Novartis AG, is a manufacturer of prescription drugs. The company portfolio includes cardio metabolic, ophthalmology, respiratory, neuroscience, immunology and dermatology, oncology, cell and gene therapy. It provides medicines such as terbinafine hydrochloride, ceritinib, dabrafenib, nilotinib, rivastigmine tartrate, panobinostat, valsartan and hydrochlorothiazide USP and methylphenidate hydrochloride. Novartis markets products in subcutaneous injections, oral granules, soft gelatin capsules, and chewable tablets and suspensions forms.
Novartis Pharmaceuticals Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.